FDA DEVICE FACTS
Critical Care Suite with Pneumothorax Detection AI Algorithm, Critical Care Suite 2.1, Critical Care Suite
Ge Medical Systems, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Critical Care Suite with Pneumothorax Detection AI Algorithm is intended to aid a clinician in the detection and localization of a pneumothorax on frontal chest radiographic images. Critical Care Suite with Pneumothorax Detection AI Algorithm is a computer-aided triage, notification, and diagnostic device that analyzes frontal chest X-ray images for the presence of a pneumothorax. Critical Care Suite identifies and highlights images with a pneumothorax to enable case prioritization or triage and assist as a concurrent reading aid during interpretation of radiographs. Intended users include qualified, independently licensed healthcare professionals trained to independently assess the presence of pneumothoraces in radiographic images and radiologists. Critical Care Suite should not be used in lieu of full patient evaluation or solely relied upon to make or confirm a diagnosis. It is not intended to replace review of the X-ray image by a qualified physician. Critical Care Suite is indicated for adults and transitional adolescents (18 to less than 22 years old but treated like adults).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。